Outcome by disease category
| . | LGNHL . | HGNHL . | HD . | MCL . |
|---|---|---|---|---|
| OS at 2 y, % | 65 | 46.7 | 56.3 | 12.8 |
| TRM | ||||
| At 100 d, % | 11.5 | 14.5 | 11.5 | 13.6 |
| At 1 y, % | 22.2 | 29.6 | 17.3 | 46 |
| At 2 y, % | 30.9 | 36.7 | 17.3 | 82 |
| Progression rate at 1 y, % | 21.1 | 47 | 28.8 | 48.2 |
| Progression rate at 2 y, % | 21.1 | 78.8 | 45.8 | 100 |
| PFS at 2 y, % | 54 | 12.9 | 42 | 0 |
| . | LGNHL . | HGNHL . | HD . | MCL . |
|---|---|---|---|---|
| OS at 2 y, % | 65 | 46.7 | 56.3 | 12.8 |
| TRM | ||||
| At 100 d, % | 11.5 | 14.5 | 11.5 | 13.6 |
| At 1 y, % | 22.2 | 29.6 | 17.3 | 46 |
| At 2 y, % | 30.9 | 36.7 | 17.3 | 82 |
| Progression rate at 1 y, % | 21.1 | 47 | 28.8 | 48.2 |
| Progression rate at 2 y, % | 21.1 | 78.8 | 45.8 | 100 |
| PFS at 2 y, % | 54 | 12.9 | 42 | 0 |